Lifecore Biomedical Inc
NASDAQ:LFCR

Watchlist Manager
Lifecore Biomedical Inc Logo
Lifecore Biomedical Inc
NASDAQ:LFCR
Watchlist
Price: 7 USD 4.17%
Market Cap: 259.2m USD

Wall Street
Price Targets

LFCR Price Targets Summary
Lifecore Biomedical Inc

Wall Street analysts forecast LFCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LFCR is 10.2 USD with a low forecast of 10.1 USD and a high forecast of 10.5 USD.

Lowest
Price Target
10.1 USD
44% Upside
Average
Price Target
10.2 USD
46% Upside
Highest
Price Target
10.5 USD
50% Upside
Lifecore Biomedical Inc Competitors:
Price Targets
2871
Nichirei Corp
25% Upside
2280
Almarai Company SJSC
15% Upside
ORK
Orkla ASA
2% Upside
DALMIASUG
Dalmia Bharat Sugar and Industries Ltd
22% Upside
288
WH Group Ltd
25% Upside
600887
Inner Mongolia Yili Industrial Group Co Ltd
8% Upside
1332
Nippon Suisan Kaisha Ltd
36% Upside
NWL
Newlat Food SpA
3% Downside

Revenue
Forecast

Revenue Estimate
Lifecore Biomedical Inc

For the last 8 years the compound annual growth rate for Lifecore Biomedical Inc's revenue is -15%. The projected CAGR for the next 4 years is 12%.

-15%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Lifecore Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Lifecore Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
66%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LFCR's stock price target?
Price Target
10.2 USD

According to Wall Street analysts, the average 1-year price target for LFCR is 10.2 USD with a low forecast of 10.1 USD and a high forecast of 10.5 USD.

What is Lifecore Biomedical Inc's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Lifecore Biomedical Inc's revenue is -15%. The projected CAGR for the next 4 years is 12%.

Back to Top